BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

981 related articles for article (PubMed ID: 19644956)

  • 1. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
    Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
    J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
    Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
    Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling.
    Shen MR; Hsu YM; Hsu KF; Chen YF; Tang MJ; Chou CY
    Carcinogenesis; 2006 May; 27(5):962-71. PubMed ID: 16400188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer.
    Kanao H; Enomoto T; Kimura T; Fujita M; Nakashima R; Ueda Y; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Tanigami A; Yoshino K; Murata Y
    Cancer Res; 2005 Oct; 65(19):8640-5. PubMed ID: 16204031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer.
    Zhang W; Jiang B; Guo Z; Sardet C; Zou B; Lam CS; Li J; He M; Lan HY; Pang R; Hung IF; Tan VP; Wang J; Wong BC
    Carcinogenesis; 2010 Jul; 31(7):1220-9. PubMed ID: 20460358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
    Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
    Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
    Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
    BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer.
    Zhang Z; Huettner PC; Nguyen L; Bidder M; Funk MC; Li J; Rader JS
    Oncogene; 2006 Aug; 25(39):5436-45. PubMed ID: 16607278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
    Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epithelial-mesenchymal transition in cancer progression].
    Gos M; Miłoszewska J; Przybyszewska M
    Postepy Biochem; 2009; 55(2):121-8. PubMed ID: 19824467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of epithelial plasticity in tumor progression.
    Jechlinger M; Grunert S; Tamir IH; Janda E; Lüdemann S; Waerner T; Seither P; Weith A; Beug H; Kraut N
    Oncogene; 2003 Oct; 22(46):7155-69. PubMed ID: 14562044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth.
    Garg M; Kanojia D; Suri S; Suri A
    Cancer; 2009 Dec; 115(24):5688-99. PubMed ID: 19813278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ cell-specific heat shock protein 70-2 is expressed in cervical carcinoma and is involved in the growth, migration, and invasion of cervical cells.
    Garg M; Kanojia D; Saini S; Suri S; Gupta A; Surolia A; Suri A
    Cancer; 2010 Aug; 116(16):3785-96. PubMed ID: 20564126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
    Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
    Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
    Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED
    Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
    Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.